Combo HCV Pill Effective in Certain Refractory Patients

(MedPage Today) -- High SVR12 rate for 16 week glecaprevir/pibrentasvir regimen in HCV GT1 patients

Source: MedPage Today Gastroenterology - November 11, 2018 Category: Gastroenterology Source Type: news